Literature DB >> 17692004

Automated electrophysiology in drug discovery.

B T Priest1, A M Swensen, O B McManus.   

Abstract

Ion channels play essential roles in nervous system signaling, electrolyte transport, and muscle contraction. As such, ion channels are important therapeutic targets, and the search for compounds that modulate ion channels is accelerating. In order to identify and optimize ion channel modulators, assays are needed that are reliable and provide sufficient throughput for all stages of the drug discovery process. Electrophysiological assays offer the most direct and accurate characterization of channel activity and, by controlling membrane potential, can provide information about drug interactions with different conformational states. However, these assays are technically challenging and notoriously low-throughput. The recent development of several automated electrophysiology platforms has greatly increased the throughput of whole cell electrophysiological recordings, allowing them to play a more central role in ion channel drug discovery. While challenges remain, this new technology will facilitate the pharmaceutical development of ion channel modulators.

Mesh:

Substances:

Year:  2007        PMID: 17692004     DOI: 10.2174/138161207781368701

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  10 in total

Review 1.  R type anion channel: a multifunctional channel seeking its molecular identity.

Authors:  Eugene Diatloff; Rémi Peyronnet; Jean Colcombet; Sébastien Thomine; Hélène Barbier-Brygoo; Jean-Marie Frachisse
Journal:  Plant Signal Behav       Date:  2010-11-01

2.  Comparative analysis of inactivated-state block of N-type (Ca(v)2.2) calcium channels.

Authors:  Timothy A Vortherms; Andrew M Swensen; Wende Niforatos; James T Limberis; Torben R Neelands; Richard S Janis; Rama Thimmapaya; Diana L Donnelly-Roberts; Marian T Namovic; Di Zhang; C Brent Putman; Ruth L Martin; Carol S Surowy; Michael F Jarvis; Victoria E Scott
Journal:  Inflamm Res       Date:  2011-03-11       Impact factor: 4.575

Review 3.  An introduction to QT interval prolongation and non-clinical approaches to assessing and reducing risk.

Authors:  Chris E Pollard; N Abi Gerges; M H Bridgland-Taylor; A Easter; T G Hammond; J-P Valentin
Journal:  Br J Pharmacol       Date:  2010-01       Impact factor: 8.739

Review 4.  Inhibition of NaV1.7: the possibility of ideal analgesics.

Authors:  Yutaka Kitano; Tsuyoshi Shinozuka
Journal:  RSC Med Chem       Date:  2022-08-01

Review 5.  Strategies to reduce the risk of drug-induced QT interval prolongation: a pharmaceutical company perspective.

Authors:  C E Pollard; J-P Valentin; T G Hammond
Journal:  Br J Pharmacol       Date:  2008-05-26       Impact factor: 8.739

6.  Dynamics of T-Junction Solution Switching Aimed at Patch Clamp Experiments.

Authors:  Jerónimo A Auzmendi; Mariano Smoler; Luciano Moffatt
Journal:  PLoS One       Date:  2015-07-15       Impact factor: 3.240

7.  A new electro-optical approach for conductance measurement: an assay for the study of drugs acting on ligand-gated ion channels.

Authors:  A Menegon; S Pitassi; N Mazzocchi; L Redaelli; R Rizzetto; J F Rolland; C Poli; M Imberti; A Lanati; F Grohovaz
Journal:  Sci Rep       Date:  2017-03-21       Impact factor: 4.379

8.  A comparison of the performance and application differences between manual and automated patch-clamp techniques.

Authors:  Xiao Yajuan; Liang Xin; Li Zhiyuan
Journal:  Curr Chem Genomics       Date:  2012-12-28

9.  Ion channels as drug targets: the next GPCRs.

Authors:  Gregory J Kaczorowski; Owen B McManus; Birgit T Priest; Maria L Garcia
Journal:  J Gen Physiol       Date:  2008-04-14       Impact factor: 4.086

10.  Machine learning for automatic prediction of the quality of electrophysiological recordings.

Authors:  Thomas Nowotny; Jean-Pierre Rospars; Dominique Martinez; Shereen Elbanna; Sylvia Anton
Journal:  PLoS One       Date:  2013-12-04       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.